Low birth weight (LBW) increases infant morbidity and mortality worldwide. One well-established risk factor is maternal smoking. Environmental tobacco smoke (ETS) exposure has recently been focused on as another potential risk factor. In this article, we review epidemiologic literature on the effects of ETS on LBW and intrauterine growth retardation (IUGR), the cause of LBW related to maternal smoking. As we consider the feasibility of modifying women's exposure, we focus our discussion on workplace exposure to ETS. The workplace is particularly important to consider because women of child-bearing age are present in the workplace in greater numbers now than ever before. In addition, certain subgroups of working women may be particularly at risk from the effects of ETS on pregnancy because they work in environments with higher exposure or they are more susceptible to its effects. We conclude that there is consistent evidence to relate maternal ETS exposure to an increased risk of adverse pregnancy outcomes and that this association may be generalized to the work environment. In studies with positive findings, infants exposed to ETS antenatally were 1.5-4 times more likely to be born with LBW, but few studies examined LBW. Most studies looked at measures of IUGR. ETS was associated with reductions in birth weight (adjusted for gestational age) ranging from 25 to 90 g. Infants born to women exposed to ETS were generally 2-4 times more likely to be born small-for-gestational age. ETS exposure in the workplace can and should be minimized to protect pregnant women from its adverse effects. Key words: birth weight, cotinine, environmental tobacco smoke, intrauterine growth retardation, low birth weight, nicotine, passive smoke, pregnancy, small for gestational age, smoking, women, workplace.
Low birth weight ([LBW] < 2500 g) is the leading cause of infant mortality in the United States. Approximately 7.4% of all births in 1995 were LBW, a proportion that has changed little in the past two decades (1) . Smoking is one of the few modifiable risk factors for LBW. There is an abundance of evidence linking maternal smoking to LBW with relative risk estimates in the range of 2-4 (2) . Two unfavorable birth outcomes, not mutually exclusive, result in low birth weight: preterm delivery and intrauterine growth retardation (IUGR). The adverse effects of maternal smoking on LBW appear to operate through an effect on IUGR rather than through an effect on preterm delivery. Maternal smoking has consistently been demonstrated to increase the risk of IUGR and to reduce mean birth weight by approximately 150-250 g (2) . There is a dose-response relationship between maternal smoking and adverse pregnancy outcomes with a stepwise increase in risk with an increased number of cigarettes smoked per day (2) . However, the timing of the exposure (maternal smoking) influences its effects on pregnancy outcomes. The adverse effects on LBW and IUGR are largely limited to smoking in the second half of pregnancy; women who quit smoking by the second half of pregnancy do not have an increased risk of poor outcomes (3) (4) (5) . The biologic mechanism by which maternal smoking causes growth retardation has not been definitely established. The current evidence suggests that the impairment of growth associated with maternal smoking results from reduced oxygen flow to the fetus. The maternal blood supply to the placenta is reduced and its oxygen load attenuated by the increased maternal carboxyhemoglobin levels associated with maternal smoking (2, 6) . This association between maternal smoking and LBW fulfills many of the causal criteria (strength of association, consistency, dose response, reversibility, and biologic plausibility) and has been judged to be causal in the Surgeon General's report (3) .
The weight of evidence linking maternal smoking with LBW has led to concern about the effects of environmental tobacco smoke (ETS) . In addition, many of the chemicals in cigarette smoke, including nicotine and carbon monoxide, are present in higher concentrations in undiluted sidestream smoke than in the (mainstream) smoke inhaled by the smoker (7, 8) . Of course, ETS comprises diluted sidestream smoke and exhaled mainstream smoke. Early studies (1960s) reported small effects on birth weight associated with in utero exposure to paternal smoking among nonsmoking mothers (9, 10) . These studies were limited in their ability to assess exposure and to control for potential confounders. Beginning in the 1980s, as effects of ETS on children were recognized, there has been renewed interest in this issue. Studies of ETS and pregnancy outcomes have generally continued to be based on a woman's report of ETS exposures, although sources of ETS other than the father's smoking have been considered. Recently, a few studies have incorporated biomarkers of exposure, either cotinine (a nicotine metabolite) or nicotine levels in the pregnant or postpartum woman. ETS exposure in pregnant women increases levels of nicotine and cotinine in pregnant women and in their amniotic fluid (11, 12) . In most studies of ETS and pregnancy, birth weight adjusted for gestational age (a proxy for IUGR) or birth weight alone has been the focus with LBW itself less frequently examined. Based on the studies of maternal smoking, IUGR (assessed by small-for-gestational age [SGA] [e.g., < 5th or < 10th percentile of birth weight for gestation, > 2 SD (standard deviation) below the mean birth weight for gestation] or birth weight adjusted for gestational age) and LBW are indeed the most appropriate outcomes to consider.
Review of ETS-LBW Literature
A review of the published literature on the relationship between ETS and LBW, birth weight, and IUGR (Table 1) was completed using the MEDLINE database (National Library of Medicine, Bethesda, MD) through 1998 and the bibliographies of individual papers. We a priori defined criteria for inclusion of a study to synthesize the current state of knowledge. These criteria were applied to all studies regardless of their findings. Studies were excluded if they did not a) describe clearly how the exposure to ETS was determined (no such studies in fact were found); b) clearly separate active smokers exposed to ETS from nonsmokers exposed to ETS (13); c) consider potential confounders such as socioeconomic status (14) (15) (16) (17) (18) , birth weight analysis only (19) ; d) provide no assessment of statistical significance (10, 15, 17, 20, 21) ; or e) characterize the study population (21, 22 In 4 of the 11 studies examining the effect on birth weight (adjusted and unadjusted for gestational age), the reductions in birth weight were statistically significant ( Figure 1 , Table 1 ). Although not all of the differences in mean birth weight were statistically significant, the estimates of the difference in mean birth weights for 10 of the 11 studies were negative, falling between -25 and -125 g. In the three studies (31) (32) (33) (24) Matthai (25) Lazzaroni (26) Eskenazi (27) Martinez (28) Zhang (29) Martin ( 'W. The pooled odds ratio tutes and are easier to obtain (41) . Nicotine lies of LBW that adjusted in bodily fluids alone has a very short half-life s was 1.38 (95% CI: (-2-3 hr) and therefore can measure only the most acute exposures (41) . However, nicotine levels assessed in hair do not have this same limitation and nicotine levels in e method of determining hair reflect tobacco smoke exposure over the iay account for some of the past few months (43) (44) (45) (46) . A biomarker ong these studies; they may assessment of ETS may also be more valid h studies' results are more than self-reported exposure because it can ng a conclusion about the account for differences in exposure not capany of the studies relied on tured by reporting the number of hours one ;s exposure to ETS. Use of is exposed to ETS. For example, differences res rather than biomarkers in ventilation of the environment can affect rential or nondifferential the biologic burden received and would be Nondifferential misclassifi-ignored by a self-reported assessment of expotenuate real associations sure. Compared to self-report, differential birth outcomes. If exposure misclassification would be much less likely Lnderestimated using self-and nondifferential misclassification also rela-,attentuation of the associ-tively less likely. However, biomarkers inte-5 and birth outcomes could grate all sources of exposure and cannot o more difficult to compare separate different sources. Self-reported )sure across studies, as the assessment is crucial if one wishes to study gories were rarely similar.
effects of exposure by specific source (e.g., studies have used either home, workplace). or both biomarkers and Among the four studies that used biologic e, primarily two biomarkers measurements rather than self-report, three been assessed in pregnant reported significant associations with adverse a nicotine metabolite; and pregnancy outcomes. Nafstad et al. (38) onent of cigarette smoke. found a significant increased risk of SGA have established cotinine (growth retardation) associated with high lid biomarkers for maternal nicotine levels in hair, categorized in quartg (40) (41) (42) . It should be tiles, in nonsmokers. Rebagliato et al. (24) iat bodily fluid (e.g., blood, found a significant reduction in birth weight, nine levels reflect exposure adjusted for gestational age, associated with r period (half-life -17 hr) high cotinine levels, also categorized in quinnot capture chronic expo-tiles, in nonsmokers. This is consistent with 1). Blood levels of nicotine the findings of Haddow et al. (32) who Lrate proxy for the dose of reported that high serum cotinine levels in ed from ETS exposure. nonsmokers were associated with significantly ;tudies of ETS have used decreased birth weight adjusted for gestancentrations because these tional age. Eskenazi et al. (27) also used l found to be valid substi-serum cotinine, classified dichotomously (2-10 ng/mL vs < 2 ng/mL) to assess ETS exposure but found no significant effect on Ahluwalia (39) smokers were classified as exposed to ETS In (RR) based on cotinine levels (2-10 ng/mL). This is in contrast to the Rebagliato et al. study 1 weight related to environmental (24) in which the prevalence of exposure in re. Studies labeled by first author the highest quintile was nearly 20% (1.8-14 tudies marked with an asterisk (*) ng/mL) and the Haddow et al. study (32) (27) compared to the Rebagliato et al. study (24) .
Critical Period of Exposure
The timing of the ETS exposure is an important issue addressed explicitly by only one of the studies. Studies of maternal smoking in pregnancy have consistently shown that it is only smoking in the second half of pregnancy that exerts a significantly adverse effect on LBW, IUGR, and birth weight (4, 5) . Therefore, one might also expect ETS exposures limited to the first half of pregnancy to exert little or no effect. Failure to separate early and late exposures might dilute the estimated effects. There is reason to expect that ETS exposures might change over the course of pregnancy, particularly ETS exposure in the workplace. Women may stop working as their pregnancy progresses and partners and co-workers might reduce their smoking around a woman as she becomes visibly pregnant. Nonsmoking pregnant women might become more active in their attempts to reduce ETS exposures as their pregnancy progresses. The one study (47) that explicitly examined ETS in late pregnancy found an increased risk of LBW, albeit not significant, of workplace ETS exposure in later pregnancy (OR = 1.83) but no substantial increase in risk for workplace ETS exposure overall (OR = 1.21). Although the other studies reviewed did not explicitly examine ETS exposures by gestation, the questions and timing of interviews and/or biomarker assessment offer some clues. Nearly all the interview studies asked women about their exposures generally during pregnancy and did not specify the time period of interest. In two studies, those by Ahluwalia et al. (39) and Martin and Bracken (30) , the questions were asked at the first prenatal visit. Neither article provides information on the mean gestational age at first visit. However, even with low income populations in the United States, which comprised the study population, most women obtaining prenatal care do so before the 20th week of pregnancy. A study conducted in Sweden (37) also asked about ETS at the first prenatal visit and noted that the mean gestational age at first visit was 12 weeks. Therefore, these three studies presumably assessed ETS exposure in the first half of pregnancy. The Haddow et al. study (32) relied on serum cotinine measured in the Environmental Health Perspectives * Vol 107, Supplement 6 * December 1999 second trimester and also presumably assessed exposure in the first half of pregnancy. All these studies found strong adverse effects of ETS that might suggest that exposure to ETS did not change during pregnancy. The Martinez et al. study (28) , which interviewed families postnatally about paternal smoking and ETS assessment, would be expected to represent the entire pregnancy with a possible bias toward representing exposure in the latter part of pregnancy due to length of recall. In this study, a statistically significant trend of decreasing birth weight with increasing exposure dose was reported. Two of the studies employing biomarkers collected their samples in the third trimester: Eskenazi et al. (27) analyzed cotinine from samples collected at 27-28 weeks gestation and Rebagliato et al. (24) analyzed cotinine from samples collected in the third trimester. The Eskenazi et al. study (27) reported no significant association between high levels of cotinine and birth weight, whereas the Rebagliato et al. study (24) found a significant reduction in birth weight associated with similar levels of cotinine. Nafstad et al. (38) collected hair samples for nicotine analysis in the immediate postpartum period, which would represent the few months of exposure. Presumably, then, the measure of ETS in the Nafstad et al. study (38) would capture exposure in the last trimester of pregnancy. As noted above, this study did find a strong association between nicotine level and risk of SGA.
Outcome Measure
The choice of outcome measure is also important to consider. Overall, there appear to be stronger effects of ETS on LBW and SGA than on birth weight (adjusted or not for gestational age). This difference is informative and may help us to understand how ETS exposure acts. The discrepancies in findings suggest that the reduction in birth weight is not uniform across the full distribution of birth weight. A uniform reduction in birth weight across the distribution of birth weight would result in some increase in LBW or SGA. The size of the effect of ETS exposure on LBW and SGA is often large, however, with ORs of 2 or greater. This effect is more similar to effects seen for maternal smoking during pregnancy, whereas the birth weight effects are much smaller than those for maternal smoking. Perhaps the reduction in birth weight is larger for infants at the lower end of the birth weight distribution. Martin and Bracken (30) also observe that while the decrease in birth weight is relatively small compared to that of direct maternal smoking, the reduction "appears to operate on the low end of the birth weight distribution, thereby increasing risk" of LBW. Perhaps infants born in the lower end of the birth weight distribution are more likely to be exposed to ETS, and several studies have previously demonstrated that women of low socioeconomic status are at increased risk for LBW (48) . The stronger effect of ETS on LBW compared to birth weight is also important with regard to infant outcomes. Although reductions in birth weight are associated with increases in infant mortality across the entire birth weight continuum, reductions in birth weight that lead to LBW are much more hazardous. Approximately two-thirds of all infants deaths in the United States in 1995 occurred to infants born with LBW (1). Infants born with LBW are also more likely to have neurodevelopmental problems such as cerebral palsy (49) . Therefore, the effects of ETS on LBW are relatively more important in terms of policy than the effects of ETS on birth weight alone.
Confounding
All these studies have considered the potential for confounding of the association between exposure to ETS and birth outcomes. In many of the studies, a wide range of covariates have been included in the final models to produce unconfounded estimates of effect. The obvious potential confounders have been considered. There is some risk, however, that these studies may have controlled for covariates that should not be considered confounders but rather are part of the causal pathway. This may be particularly true of studies considering ETS in the workplace. ETS exposure may indeed be higher in workplaces in which working conditions are more strenuous. Increased ETS levels may be the result of these working conditions and controlling for them in the analysis may remove the very real effects of ETS. This is especially problematic with regard to socioeconomic status. As stated earlier, socioeconomic status is a very strong predictor of LBW risk and also may be related to ETS exposure. The higher ETS exposure levels may be part of the explanation for the increased risk of LBW to women of low socioeconomic status. Therefore controlling for socioeconomic status would mask a real effect of ETS.
Stadstical Power
Given that the effect size is likely small and the prevalence of exposure may vary depending on the population, inadequate statistical power to detect the effects may be a source of inconsistency in the findings reported for ETS and birth outcomes. The only one of the four studies using a biomarker that did not find a significant effect of ETS had an extremely low rate of exposure (less than 10% of women were classified as exposed based on the cotinine levels in the Eskenazi study). Discussion LBW increases infant morbidity and mortality worldwide. One well-established risk factor is maternal smoking. ETS exposure has recently been focused on as another potential risk factor. As we consider the feasibility of modifying women's exposure, we have focused our discussion on workplace exposure to ETS. The workplace is particularly important to consider because women of child-bearing age are present in the workplace in greater numbers than ever before. In 1994 (the most recent data available), there were 60 million women in the U.S. labor force and those women made up 46% of the total U.S. labor force. Between the ages of 20 and 44, the peak child-bearing years for women, labor force participation rates exceeded 70% for women (50). In addition, certain subgroups of working women may be particularly at risk from the effects of ETS on pregnancy because they work in environments with higher exposure or are more susceptible to its effects. In 1994, 10 (59) (also referred to as TANF, Temporary Assistance to Needy Families), more pregnant women from these disadvantaged groups will be in the workplace with little or no control over their working conditions except for government regulations (60) . For all these reasons, ETS exposure is an issue of particular concern with regard to pregnancy outcomes in this population. Poor women are also more likely to be smokers themselves (61) and may be more likely to be exposed to other substances or conditions that increase the risk of LBW.
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Conclusion
In summary, ETS exposure appears to have adverse effects on fetal growth parallel to what is seen for maternal smoking, but, as would be expected with less exposure, effects are generally smaller than those for maternal smoking. As a consequence, morbidity and mortality would be expected to be higher for infants born to women exposed to ETS during pregnancy. The workplace is one source of exposure to ETS for pregnant women that can and should be minimized to reduce risk of adverse pregnancy outcomes for working women.
